271 related articles for article (PubMed ID: 33774805)
21. PARP Inhibitors Talazoparib and Niraparib Sensitize Melanoma Cells to Ionizing Radiation.
Jonuscheit S; Jost T; Gajdošová F; Wrobel M; Hecht M; Fietkau R; Distel L
Genes (Basel); 2021 May; 12(6):. PubMed ID: 34073147
[TBL] [Abstract][Full Text] [Related]
22. Antitumor, Inhibition of Metastasis and Radiosensitizing Effects of Total Nutrition Formula on Lewis Tumor-Bearing Mice.
Liu YM; Chan YL; Wu TH; Li TL; Hsia S; Chiu YH; Wu CJ
Nutrients; 2019 Aug; 11(8):. PubMed ID: 31426614
[TBL] [Abstract][Full Text] [Related]
23. Enhanced efficacy of AZD3759 and radiation on brain metastasis from EGFR mutant non-small cell lung cancer.
Li X; Wang Y; Wang J; Zhang T; Zheng L; Yang Z; Xing L; Yu J
Int J Cancer; 2018 Jul; 143(1):212-224. PubMed ID: 29430654
[TBL] [Abstract][Full Text] [Related]
24. Carbon ion irradiation exerts antitumor activity by inducing cGAS-STING activation and immune response in prostate cancer-bearing mice.
Hu W; Zhang Z; Xue Y; Ning R; Guo X; Sun Y; Zhang Q
Cancer Med; 2024 Jan; 13(2):e6950. PubMed ID: 38379323
[TBL] [Abstract][Full Text] [Related]
25. BIBR1532 combined with radiotherapy induces ferroptosis in NSCLC cells and activates cGAS-STING pathway to promote anti-tumor immunity.
Bao Y; Pan Z; Zhao L; Qiu J; Cheng J; Liu L; Qian D
J Transl Med; 2024 May; 22(1):519. PubMed ID: 38816831
[TBL] [Abstract][Full Text] [Related]
26. PARP inhibitor plus radiotherapy reshape the immune suppressive microenvironment and potentiate the efficacy of immune checkpoint inhibitors in tumors with IDH1 mutation.
Hu X; Zhao M; Bai M; Xue Z; Wang F; Zhu Z; Yu J; Yue J
Cancer Lett; 2024 Apr; 586():216676. PubMed ID: 38278469
[TBL] [Abstract][Full Text] [Related]
27. PARP inhibitors combined with ionizing radiation induce different effects in melanoma cells and healthy fibroblasts.
Weigert V; Jost T; Hecht M; Knippertz I; Heinzerling L; Fietkau R; Distel LV
BMC Cancer; 2020 Aug; 20(1):775. PubMed ID: 32811446
[TBL] [Abstract][Full Text] [Related]
28. Autophagy suppression enhances DNA damage and cell death upon treatment with PARP inhibitor Niraparib in laryngeal squamous cell carcinoma.
Ji Y; Wang Q; Zhao Q; Zhao S; Li L; Sun G; Ye L
Appl Microbiol Biotechnol; 2019 Dec; 103(23-24):9557-9568. PubMed ID: 31686145
[TBL] [Abstract][Full Text] [Related]
29. AZD5438, an inhibitor of Cdk1, 2, and 9, enhances the radiosensitivity of non-small cell lung carcinoma cells.
Raghavan P; Tumati V; Yu L; Chan N; Tomimatsu N; Burma S; Bristow RG; Saha D
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e507-14. PubMed ID: 22795803
[TBL] [Abstract][Full Text] [Related]
30. Targeting PARP and autophagy evoked synergistic lethality in hepatocellular carcinoma.
Zai W; Chen W; Han Y; Wu Z; Fan J; Zhang X; Luan J; Tang S; Jin X; Fu X; Gao H; Ju D; Liu H
Carcinogenesis; 2020 May; 41(3):345-357. PubMed ID: 31175354
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation.
Chen N; Fang W; Zhan J; Hong S; Tang Y; Kang S; Zhang Y; He X; Zhou T; Qin T; Huang Y; Yi X; Zhang L
J Thorac Oncol; 2015 Jun; 10(6):910-23. PubMed ID: 25658629
[TBL] [Abstract][Full Text] [Related]
32. PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer.
Chabanon RM; Muirhead G; Krastev DB; Adam J; Morel D; Garrido M; Lamb A; Hénon C; Dorvault N; Rouanne M; Marlow R; Bajrami I; Cardeñosa ML; Konde A; Besse B; Ashworth A; Pettitt SJ; Haider S; Marabelle A; Tutt AN; Soria JC; Lord CJ; Postel-Vinay S
J Clin Invest; 2019 Mar; 129(3):1211-1228. PubMed ID: 30589644
[TBL] [Abstract][Full Text] [Related]
33. Effect of PF-02341066 and radiation on non-small cell lung cancer cells.
Tumati V; Kumar S; Yu L; Chen B; Choy H; Saha D
Oncol Rep; 2013 Mar; 29(3):1094-100. PubMed ID: 23254764
[TBL] [Abstract][Full Text] [Related]
34. PLK1 and EGFR targeted nanoparticle as a radiation sensitizer for non-small cell lung cancer.
Reda M; Ngamcherdtrakul W; Gu S; Bejan DS; Siriwon N; Gray JW; Yantasee W
Cancer Lett; 2019 Dec; 467():9-18. PubMed ID: 31563561
[TBL] [Abstract][Full Text] [Related]
35. Combination of Niraparib, Cisplatin and Twist Knockdown in Cisplatin-Resistant Ovarian Cancer Cells Potentially Enhances Synthetic Lethality through ER-Stress Mediated Mitochondrial Apoptosis Pathway.
Bahar E; Kim JY; Kim DC; Kim HS; Yoon H
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920140
[TBL] [Abstract][Full Text] [Related]
36. The poly(ADP-Ribose) polymerase inhibitor ABT-888 reduces radiation-induced nuclear EGFR and augments head and neck tumor response to radiotherapy.
Nowsheen S; Bonner JA; Yang ES
Radiother Oncol; 2011 Jun; 99(3):331-8. PubMed ID: 21719137
[TBL] [Abstract][Full Text] [Related]
37. Thoracic radiotherapy and concurrent almonertinib for unresectable stage III EGFR-mutated non-small-cell lung cancer: a phase 2 study.
Zhu L; Zou C; Zhang Z; Wang J; Yang L; Rao C; Yang Z; Liang J; Xia B; Shenglin MA
BMC Cancer; 2021 May; 21(1):511. PubMed ID: 33962566
[TBL] [Abstract][Full Text] [Related]
38. Transcutaneous Vagal Nerve Stimulation Alone or in Combination With Radiotherapy Stimulates Lung Tumor Infiltrating Lymphocytes But Fails to Suppress Tumor Growth.
Reijmen E; De Mey S; Van Damme H; De Ridder K; Gevaert T; De Blay E; Bouwens L; Collen C; Decoster L; De Couck M; Laoui D; De Grève J; De Ridder M; Gidron Y; Goyvaerts C
Front Immunol; 2021; 12():772555. PubMed ID: 34925341
[TBL] [Abstract][Full Text] [Related]
39. EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
Gong H; Li Y; Yuan Y; Li W; Zhang H; Zhang Z; Shi R; Liu M; Liu C; Chen C; Liu H; Chen J
BMC Cancer; 2020 Dec; 20(1):1189. PubMed ID: 33276757
[TBL] [Abstract][Full Text] [Related]
40. Sensitization to radiation and alkylating agents by inhibitors of poly(ADP-ribose) polymerase is enhanced in cells deficient in DNA double-strand break repair.
Löser DA; Shibata A; Shibata AK; Woodbine LJ; Jeggo PA; Chalmers AJ
Mol Cancer Ther; 2010 Jun; 9(6):1775-87. PubMed ID: 20530711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
